Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Isogawa

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Intestinal Research|May 11, 2018
Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studiesSatoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, et al.
The Journal of Dermatology|July 18, 2017
Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trialMasatoshi Abe, Chikako Nishigori, Hideshi Torii, et al.
Pain Management|November 17, 2021
Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety studyShin-Ichi Konno, Takuya Nikaido, John D Markman, et al.
European Journal of Pain (London, England)|March 17, 2021
Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?Francis Berenbaum, Richard Langford, Serge Perrot, et al.
Intestinal Research|February 5, 2020
Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn's disease in Japanese and Korean patients: the OPERA studyMasayuki Saruta, Dong Il Park, Young-Ho Kim, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Intestinal Research|May 11, 2018
Tofacitinib induction and maintenance therapy in East Asian patients with active ulcerative colitis: subgroup analyses from three phase 3 multinational studiesSatoshi Motoya, Mamoru Watanabe, Hyo Jong Kim, et al.
The Journal of Dermatology|July 18, 2017
Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trialMasatoshi Abe, Chikako Nishigori, Hideshi Torii, et al.
Pain Management|November 17, 2021
Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety studyShin-Ichi Konno, Takuya Nikaido, John D Markman, et al.
European Journal of Pain (London, England)|March 17, 2021
Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?Francis Berenbaum, Richard Langford, Serge Perrot, et al.
Intestinal Research|February 5, 2020
Anti-MAdCAM-1 antibody (PF-00547659) for active refractory Crohn's disease in Japanese and Korean patients: the OPERA studyMasayuki Saruta, Dong Il Park, Young-Ho Kim, et al.
Pageof 2